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CC BY-NC-ND license (http://creativeAbstract Background: Streptococcus agalactiae [group B Streptococcus (GBS)] has become
more prevalent in nonpregnant women, the elderly, and people who are immunocompromised.
We investigated the serotype and genomic changes of GBS human isolates from different hos-
pitals from 2007 to 2012.
Methods: The serotype and genotype of 658 GBS human isolates were determined with multi-
plex polymerase chain reaction and pulsed field gel electrophoresis analysis. Multilocus
sequence typing analysis determined the sequence type (ST) of the major clones of serotypes
Ib, V, and VI.
Results: Most of the isolates were collected from urine samples (60.5%) with a reduction in the
rate from 74.6% in 2007 to 34.5% in 2012 and from infected patients older than 30 years
(72.6%). The female/male ratio differed depending on the source: 3.52 in the urine group,
0.48 in the wound group, and 0.43 in pus. Serotypes Ib (16.5%), III (16.9%), V (27.2%), and VI
(17.6%) were the most predominant among the nine serotypes identified and were separated
into two prevalence patterns: a decrease in serotypes Ib and V and an increase in serotypes
III and VI from 2007 to 2012. The prevalence change was associated with the urine group.t of Microbiology, Immunology, and Biopharmaceuticals, National Chiayi University, 300 University
edu.tw (C. Chu).
.05.022
Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
Serotypic genomic variations 673Additionally, serotype VI become more prevalent in blood samples in four hospitals. The pulsed
field gel electrophoresis analysis demonstrated three genetic patterns: limited pulsotypes and
a major clonal dissemination for serotypes Ib and V, diverse pulsotypes for serotypes III, and
diverse pulsotypes with a major clonal dissemination for serotype VI. Multilocus sequence
typing analysis of the major clones identified ST12 for serotype Ib and ST1 for serotypes V
and VI.
Conclusion: Rapid genomic variations with different evolutionary patterns have led to the
establishment of serotypes III and VI as the predominant GBS serotypes.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Gram-positive Streptococcus agalactiae (group B Strepto-
coccus; GBS) is a normal human gastrointestinal and geni-
tourinary flora. Therefore, GBS commonly infects the
vagina, is more prevalent in pregnant women than
nonpregnant women,1 and causes early-onset or late-onset
sepsis in newborns. Vaccination has been used to prevent
GBS infection in neonates.2e4 However, GBS infections have
increased in immunocompromised and elderly persons and
frequently occur in the summer months.5,6
The prevalence of the GBS infection varies depending on
serotypes, countries, years, and patient age. In Taiwan,
GBS infection was higher in early-onset cases than in late-
onset cases in neonates with a rate of 0.11e1.30/per 1000
newborn children.7,8 Serotype III was the major serotype
that caused bacteremia and meningitis in patients younger
than 18 years, whereas serotype II was the major serotype
causing these diseases in nonpregnant adults.9 In Japan,
the most prevalent serotype was serotype VIII (35.8%),
followed by serotype VI (24.7%), which are more frequently
identified in pregnant women.10 In Korea, the most preva-
lent serotypes were serotypes Ib and III in 1979e2000 and
then serotypes V and III in 2006e2007.11,12 In England and
Wales, GBS caused the most common disease, meningitis, in
neonates, and serotype III was the most prevalent serotype
from 1991 to 2010.5 Multilocus sequence typing (MLST) has
been used for the phylogenetic analysis of strains in out-
breaks or recent infections.13,14
Earlier we reported that serotype V was the most prev-
alent serovar with high resistance to erythromycin (91.0%)
and clindamycin (82.1%) in 2007e2008.6 In this study, we
extended the previous study to characterize the GBS iso-
lates collected from Chiayi Chang Gung Memorial Hospital
(CGMH) during 2007e2012 and from four hospitals in 2012.
The aim of this study was to investigate the genetic change
of the four major serotypes.Materials and methods
Bacterial isolates and identification
This study was approved by the research ethics committee
of CGMH. Including the isolates from early reports,6,15 a
total of 562 GBS isolates were collected from Chiayi CGMHin 2007, 2008, 2011, and 2012. The other GBS isolates were
from Linkou (34 isolates) and Kaoshiung (23 isolates) CGMH
and Chi-Mei Hospital (CMH, 39 isolates) in 2012. The GBS
genomic DNA was purified using a DNA extraction kit
(Quality Systems, Taipei, Taiwan). Then, 50e100 ng
genomic DNA was used as the template for polymerase
chain reaction (PCR) identification of GBS and the sero-
types. Serotypes were determined by various PCR products
and size using 19 primers and conditions as previously
described.16 The PCR products were separated on a 1.5%
agarose gel. After staining with ethidium bromide, the
images were recorded and analyzed.
Genotyping by pulsed field gel electrophoresis
Briefly, 250 mL of an overnight bacterial culture was
centrifuged and resuspended with 250 mL of ddH2O. The
solution was mixed with an equal amount of 1.6% agarose to
make plugs. The plugs were treated with 1 mL of lysis so-
lution (2mM TriseHCl, 0.1M EDTA, and 1M NaCl, 1 mg/mL
lysozyme) at 37C for 12e14 hours and were then digested
with 1 mg/mL of proteinase K at 50C for 12e14 hours. The
plugs were then washed with TE buffer (10mM Tris, 1mM
EDTA, pH 8.0) at least 10 times at 37C with shaking and
were then digested with SmaI (New England Biolabs, Ips-
wich, MA, USA) at 25C for 12e16 hours. XbaI-digested
Salmonella Braenderup (H9812) was used as the size
marker. The chromosomal DNA was separated using the
following conditions: an initial switch time of 4 seconds, a
final switch time of 70 seconds, a runtime of 14 hours, an
angle of 120, and 6.5 V at 14C followed by an initial switch
time of 4 seconds, a final switch time of 70 seconds, a
runtime of 14 hours, and an angle of 120 at 4 V at 14C in a
Bio-Rad CHEF MAPPER. The gel was stained with ethidium
bromide and was then recorded and analyzed.
MLST analysis
MLST analysis was performed by sequencing the genes for
alcohol dehydrogenase (adhP), phenylalanyl tRNA synthe-
tase (pheS ), aminoacid transporter (atr), glutamine syn-
thetase (glnA), serine dehydratase (sdhA), glucose kinase
(glcK ), and transketolase (tkt).14 The PCR products were
purified with a DNA purification kit (ProTECH, Taipei,
Taiwan) and were then sequenced. The sequence was
confirmed with the National Center for Biological
674 Y.-H. Wang et al.Information BlastX program. MLST analysis was performed
on representative isolates from serotypes Ib, V, and VI using
the protocols and software provided at http://pubmlst.
org/sagalactiae/.
Results
GBS infections associated with the sampling sources
Among the 562 GBS isolates, the predominant isolates were
mainly collected from urine with a prevalence of 60.5%
(340/562); the remaining isolates were collected from
other sources, including bone, cerebrospinal fluid, dialysis
fluid, and sputum (58, 10.4%), wounds (50, 8.9%), blood (45,
8%), and pus (30, 5.3%) (Table 1). However, the prevalence
of urine isolates has changed annually with a decrease from
74.6% in 2007 to 34.5% in 2012 and an increase from 2% in
2007 to 25.1% in 2012 for the other sources with a fluctu-
ation for blood and pus.
Serotype distribution associated with age
Multiplex PCR identified nine serotypesdIa, Ib, and
IIeVIIIdfor 555 isolates; however, the serotypes could not
be identified for seven isolates (Table 2). Four major se-
rotypes accounted for 78.2% isolates with serotype V
(27.2%) being the most prevalent followed by serotype VI
(17.6%), serotype III (16.9%), and serotype Ib (16.5%). The
remaining serotypes each accounted for less than 9% of the
total isolates. By separating the patient ages into five
groups, we found that most of the GBS infections occurred
in patients in the over 30-year-old age range for all of the
serotypes (Table 2). The most prevalent serotypes were
serotypes V, VI, III, and I in all age groups; however, a
decrease in serotypes Ib and V prevalence and an increase
in serotypes III and VI prevalence was observed from 2007
to 2012 (Figure 1). Next, we investigated whether there was
a sex preference among the source groups.
Serotypes associated with sex, major isolation
sources, and years
The average female/male (F/M) ratio was 2.08, and the F/
M ratio differed among the four major source groups with a
higher rate of female infection in the urine group (3.52), a
higher rate of male infection in the pus and wound groups,
and a nearly even ratio in the blood source group (Table 3).Table 1 Source of Streptococcus agalactiae isolates from Chiay
Year AB B CX GTS PUS TS
2007 20 (10.4) 1 (0.5) 11 (5.7)
2008 2 (1.2) 9 (5.3) 1 (0.6) 8 (4.7) 1 (0
2011 4 (4.9) 2 (2.5) 4 (4.9) 5 (6.2) 1 (1
2012 1 (0.8) 12 (10.1) 3 (2.5) 16 (13.4) 6 (5) 1 (0
Total 3 (0.5) 45 (8) 6 (1.1) 21 (3.7) 30 (5.3) 3 (0
AB Z abscess; B Z blood; CX Z endocervix discharge; GTS Z genita
rebrospinal fluid (1), dialysate (1) and sputum (1); PUS Z pus; TS ZThe F/M ratio differed among serotypes with higher than
average F/M ratios for serotypes Ib, II, V, VI, and VII, a near-
average F/M ratio for serotype III, an equal F/M ratio for
serotype Ia, and a lower F/M ratio for serotype IV.
The change in prevalence of the four major serotypes
was associated with isolation sources (Table 4). For the
major sampling group from 2007 to 2012, the serotype
change in urine determined the trends of all of GBS isolates
(Table 4). However, these four serotypes differed in prev-
alence among the four major isolation sources: serotype V
was the most prevalent in the blood (28.9%) and urine
(28.5%) samples, serotype V (36.7%) in the pus samples, and
serotype VI (24.3%) in wound samples. Additionally, sero-
type III and serotype VI increased the prevalence in the
wound and blood samples, respectively, in 2012.Pulsotype change of the four major serotypes
The pulsed field gel electrophoresis analysis classified these
four major serotypes into nine pulsotypes for serotype Ib,
27 pulsotypes for serotype III, 11 pulsotypes and one non-
typable for serotype V, and 22 pulsotypes for serotype VI
(Figures 2 and 3, Table 5). Serotypes Ib, V, and VI appeared
to have a dominant clone dissemination of pulsotype I with
a prevalence of 79.4%, 66.5% and 64.8% through 4 years,
respectively, whereas serotype III showed genetic diversity
without a dominant clone. Compared with the limited
pulsotypes in serotypes Ib and V, new pulsotypes emerged
annually in serotype VI: four pulsotypes in 2008, six pulso-
types in 2011, and five pulsotypes in 2012, which indicates
that constant chromosomal variations occur in serotype VI
to increase the genetic diversity and fitness of this sero-
type. MLST analysis of two isolates from the major pulso-
type of serotypes Ib, V, and VI determined that the ST types
were ST12 for serotype Ib and ST1 for serotypes V and VI.
Next, we investigated the genetic variations of GBS
isolates from 2012 among the four hospitals although the
GBS number was limited. The most prevalent serotypes
differed among these four hospitals: serotypes III (21.8%)
and VI (28.6%) for CGMH-Chiayi, serotypes V (17.6%) and VI
(38.2%) for CGMH-Linkou, serotype Ib and VI for CGMH-
Kaoshiung, and serotype IV (28.2%) and VI (25.6%) for (CMH,
Supplementary Table S1). Major pulsotype I was the most
prevalent for serotype Ib in CGMH-Chiayi (60%,6/10),
Kaoshiung (71.4%,5/7), and CMH (100%, 3/3) hospitals and
for serotype VI in CGMH-Chiayi (65.6%, 21/32), Kaoshiung
(100%,7/7), Linkou (50%,6/12), and CMH (70%, 7/10).i Gung Memorial Hospital
U WD OTH N Total
144 (74.6) 10 (5.2) 4 (2) 3 (1.6) 193 (100)
.6) 121 (71.6) 16 (9.5) 10 (5.9) 1 (0.6) 169 (100)
.2) 34 (42) 15 (18.5) 15 (18.5) 1 (1.2) 81 (100)
.8) 41 (34.5) 9 (7.6) 30 (25.1) 119 (100)
.5) 340 (60.5) 50 (8.9) 58 (10.4) 5 (0.9) 562 (100)
l tract swab and vaginal discharge; OTH Z others, bone (1), ce-
tissue; U Z urine; WD Z wound; N Z no data.
Table 2 Association of ages with serotypes for Streptococcus agalactiae isolates from Chiayi Gung Memorial Hospital
Age Serotype[N, %] Total
Ia Ib II III IV V VI VII VIII NDa
<1 3 (15) 3 (3.2) 1 (3.1) 4 (4.2) 4 (8.2) 3 (14.3) 3 (3.0) 21 (3.7)
1w30 5 (25) 13 (14.0) 9 (28.1) 11 (11.6) 7 (14.3) 13 (16.9) 17 (17.2) 1 (8.3) 1 (14.3) 77 (13.7)
31w50 5 (25) 30 (32.3) 5 (15.6) 27 (28.4) 12 (24.5) 41 (27.2) 23 (23.2) 4 (33.3) 4 (57.1) 151 (26.9)
51w70 3 (15) 29 (31.2) 8 (25.0) 30 (31.6) 15 (30.6) 47 (27) 35 (35.3) 5 (41.7) 1 (50) 1 (14.3) 174 (31.0)
>70 4 (20) 18 (19.4) 9 (28.1) 23 (24.2) 11 (22.4) 46 (33.8) 21 (21.2) 2 (16.7) 1 (50) 1 (14.3) 136 (24.2)
Totalb 20 (3.6) 93 (16.5) 32 (5.7) 95 (16.9) 49 (8.7) 153 (27.2) 99 (17.6) 12 (2.1) 2 (0.4) 7 (1.2) 562 (100)
a Not determined.
b There were three strains belonged to serotype V without age data.
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The GBS serotypes differed genetically, and GBS infection is
associated with patient age and sources. Therefore, sero-
types evolve differently to become the prevalent serotypes
among countries, such as serotype III in Portugal17; serotypes
Ib, III, and VI in Norway18; serotypes Ia, Ib, and V from neo-
nates in the United States19; serotypes Ia, II, III, and V in theFigure 1. Pulsotypes of (A) serotype Ib, (B) V and VI isolates deUnited States and Europe20,21; serotypes Ib and III in adults
and children in Japan22; serotypes III and V in pregnant
women, neonates, and adults in Korea11; and serotypes Ia
and VI in pregnant women23 and in neonates and adults in
Malaysia.24 These results demonstrated that serotypes III, V,
and VI may be the major serotypes worldwide.
In the present study, we investigated the genetic dif-
ferences and the change in the prevalence of thetermined by pulsed field gel electrophoresis (PFGE) analysis.
Table 4 The prevalence of major serotypes in four isolation sources
Serotype Sources 2007 2008 2011 2012 Total
Ib Blood 25.0 (5/20) 11.1 (1/9) 0 (0/4) 8.3 (1/12) 15.6 (7/45)
Pus 9.1 (1/11) 37.5 (3/8) 0 (0/5) 16.6 (1/6) 16.7 (5/30)
Wound 0 (0/10) 18.8 (3/16) 0 (0/15) 0 (0/9) 6.0 (3/50)
Urea 27.8 (40/144) 14.9 (18/121) 14.7 (5/34) 9.5 (4/42) 19.7 (67/340)
Total 24.9 (46/185) 16.2 (25/154) 10.3 (6/58) 8.7 (6/69) 17.6 (82/465)
III Blood 15.0 (3/20) 11.1 (1/9) 0 (0/4) 16.7 (2/12) 13.3 (6/45)
Pus 18.2 (2/11) 0 (0/8) 20.0 (1/5) 16.7 (1/6) 13.3 (4/30)
Wound 20.0 (2/10) 6.3 (1/16) 13.3 (2/15) 44.4 (4/9) 18.0 (9/50)
Urine 17.4 (25/144) 14.0 (17/121) 23.5 (8/34) 47.6 (20/42) 20.6 (70/340)
Total 17.3 (32/185) 12.3 (19/154) 19.0 (11/58) 39.1 (27/69) 19.1 (89/465)
V Blood 25.0 (5/20) 55.6 (5/9) 25.0 (1/4) 16.7 (2/12) 28.9 (13/45)
Pus 27.3 (3/11) 50.0 (4/8) 25.0 (2/5) 33.3 (2/6) 36.7 (11/30)
Wound 40.0 (4/10) 31.3 (5/16) 0 (0/15) 11.1 (1/9) 20 (10/50)
Urine 28.5 (41/144) 35.5 (43/121) 20.6 (7/34) 14.3 (6/42) 28.5 (97/340)
Total 28.6 (53/185) 37.0 (57/154) 20.7 (12/58) 15.9 (11/69) 28.2 (131/465)
VI Blood 20.0 (4/20) 11.1 (1/9) 25.0 (1/4) 41.7 (5/12) 24.4 (11/45)
Pus 9.1 (1/11) 0 (0/8) 20.0 (1/5) 16.7 (1/6) 10.0 (3/30)
Wound 10.0 (1/10) 6.3 (1/16) 43.8 (7/16) 33.3 (3/9) 24.0 (12/50)
Urine 9.7 (14/144) 14.0 (17/121) 26.5 (9/34) 28.6 (12/42) 15.3 (52/340)
Total 10.8 (20/185) 12.3 (19/154) 31.0 (18/58) 30.4 (21/69) 16.8 (78/465)
Figure 2. Pulsotypes of (A) serotype Ib, (B) V and (C) VI isolates determined by pulsed field gel electrophoresis (PFGE) analysis.
Table 3 Association of sources with serotypes for Streptococcus agalactiae isolates from Chiayi Gung Memorial Hospital
Source Sex Serotype, n (%) Total F/M
ratioIa Ib II III IV V VI VII VIII ND
B F 2 (8.3) 2 (8.3) 3 (12.5) 9 (37.5) 7 (29.2) 1 (4.2) 24 (100) 1.14
M 1 (4.8) 5 (23.8) 2 (9.5) 3 (14.3) 1 (4.8) 5 (23.8) 4 (19) 21 (100)
PUS F 3 (33.3) 1 (11.1) 1 (11.1) 3 (33.3) 1 (11.1) 9 (100) 0.43
M 2 (9.5) 2 (9.5) 3 (14.3) 3 (14.3) 8 (38.1) 2 (9.5) 1 (4.8) 21 (100)
U F 7 (2.6) 50 (18.9) 10 (3.8) 43 (16.2) 17 (6.4) 79 (29.8) 48 (18.1) 8 (3) 1 (0.4) 2 (0.8) 265 (100) 3.52
M 6 (8) 17 (22.7) 1 (1.3) 17 (22.7) 11 (14.7) 18 (24) 4 (5.3) 1 (1.3) 75 (100)
WD F 2 (12.5) 2 (12.5) 4 (25) 4 (25) 2 (12.5) 1 (6.3) 1 (6.3) 16 (100) 0.48
M 1 (2.9) 2 (5.9) 5 (14.7) 9 (26.5) 6 (17.6) 10 (29.4) 1 (2.9) 34 (100)
Total F 7 (2.2) 57 (18.2) 15 (4.8) 51 (16.2) 17 (5.4) 95 (30.3) 58 (18.5) 8 (2.5) 2 (0.6) 4 (1.3) 314 (100) 2.08
M 7 (4.6) 25 (16.6) 7 (4.6) 28 (18.5) 24 (15.9) 37 (24.5) 20 (13.20) 3 (2.0) 151 (100)
F/M 1.00 2.28 2.14 1.82 0.71 2.58 2.9 2.67 2.08
B Z blood; ND Z not determined; OTH Z other sources; PUS Z pus; U Z urine; WD Z wound.
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Figure 3. Pulsotypes of serotype III isolates determined by pulsed field gel electrophoresis (PFGE) analysis.
Serotypic genomic variations 677predominant serotypes Ib, III, V, and VI. However, there are
three genetic patterns of the most prevalent serotypes: a
major clonal dissemination with limited pulsotypes for
serotype Ib and V, a major clonal dissemination with a large
number of a single pulsotype for serotype VI, and no major
clone with the most genetically diverse pulsotypes (Table
5). This genetic difference leads to changes in prevalence
with a decrease in serotypes Ib and V and an increase in
serotypes III and VI from 2007 to 2012, although this change
is associated with the prevalence change in the urine group
(Figure 2). Conversely, an increase in the genetic diversity
may have caused serotypes III and VI to become the mostTable 5 Number of PFGE patterns in serotype Ib, III, V,
and VI isolates
Pulsotypes Serotype, n (%)
Ib III V VI
I 77 (79.4) 4 (3.9) 109 (66.5) 81 (64.8)
II 1 (1) 3 (2.9) 14 (8.5) 6 (4.8)
III 1 (1) 6 (5.8) 1 (0.6) 2 (1.6)
IV 2 (2.1) 3 (2.9) 9 (5.5) 3 (2.4)
V 2 (2.1) 4 (3.9) 6 (3.7) 1 (0.8)
VI 2 (2.1) 12 (11.7) 4 (2.4) 4 (3.2)
VII 10 (10.3) 2 (1.9) 5 (3) 3 (2.4)
VIII 1 (1) 1 (1) 1 (0.6) 2 (1.6)
IX 1 (1) 5 (4.9) 1 (0.6) 3 (2.4)
X 2 (1.9) 1 (0.6) 2 (1.6)
XI 1 (1) 1 (0.6) 1 (0.8)
XII 4 (3.9) 4 (3.2)
XIII 1 (1) 2 (1.6)
XIV 2 (1.9) 2 (1.6)
XV 6 (5.8) 1 (0.8)
XVI 2 (1.9) 1 (0.8)
XVII 6 (5.8) 1 (0.8)
XVIII 1 (1) 1 (0.8)
XIX 2 (1.9) 1 (0.8)
XX 1 (1) 1 (0.8)
XXI 7 (6.8) 1 (0.8)
XXII 1 (1) 2 (1.6)
XXIII 3 (2.9)
XXIV 1 (1)
XXV 4 (3.9)
XXVI 5 (4.9)
XXVII 2 (1.9)
ND 9 (5.5)
Total 97 (100) 103 (100) 164 (100) 125 (100)
ND Z not determined.prevalent serotypes, especially serotype VI in the other
three hospitals in 2012.
It has been reported that there is clonal dissemination of
clonal complex 1, mostly ST1, of serotype VI in the blood
isolates in Taiwan,25 and the major clones of serotype V and
VI belong to ST1.26 In this study, we observed that serotype
VI increased in prevalence in blood samples, and serotypes
V and VI were the two most prevalent serotypes (Tables 2
and 4). Although these two serotypes belong to ST1, sero-
type VI has substituted serotype V to become the most
prevalent serotype in 2011 and 2012. Despite a major clonal
dissemination of both of these serotypes, serotype VI
evolved a large number of genotypes in the four sampled
hospitals throughout the study years (Supplementary Table
S2), whereas the prevalence of serotype V gradually
decreased and was limited in the numbers of pulsotypes.
The change in the prevalence by year is related to the rapid
evolution of a new clone from a major clone in serotype VI,
which has led to increased adaptation compared to the
conserved serotypes in serotype V.
Vaccination has been used to reduce prevalent GBS
infection in neonates. In this study, GBS infection occurs
frequently in nonpregnant female and elderly patients and
less frequently in young adults and neonates (Table 2). The
reduced infection rate in neonates is not associated with
vaccinations as vaccines have not been administered at the
study hospitals. As a normal flora component in the human
gastrointestinal and genitourinary tracts, more GBS in-
fections were observed in females than in males, and the
most dominant serotypes were Ib, III, V, and VI in urine
samples. A female prevalence was not observed in other
sources. In contrast, GBS infection was more frequently
found in the pus and wound samples from males with
serotype V as the most prevalent in pus and an almost equal
predominance of serotypes IV and VI in wounds (Table 3). In
conclusion, GBS serotype change was associated with
genomic variations, and the sample size affected the
prevalence and sex preference.Conflicts of interest
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